Filing Details

Accession Number:
0001415889-24-003767
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-14 16:56:48
Reporting Period:
2014-02-12
Accepted Time:
2024-02-14 16:56:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1192448 Glaukos Corp GKOS Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1705850 E Joseph Gilliam C/O Glaukos Corporation
One Glaukos Way
Aliso Viejo CA 92656
President & Coo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-12 1,512 $55.18 121,314 No 4 M Direct
Common Stock Disposition 2024-02-12 1,512 $96.80 119,802 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-02-12 1,512 $0.00 1,512 $55.18
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
39,936 2032-03-24 No 4 M Direct
Footnotes
  1. Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023.
  3. This transaction was executed in multiple trades at prices ranging from $96.57 to $97.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023.
  5. Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period.